Tagged flightpath-biosciences

Press Release

Flightpath Biosciences Begins Human Clinical Testing of the World’s First Narrow-Spectrum Antibiotic Targeting Lyme Disease

 Read More
Flightpath Biosciences and the Forsyth Institute Enter Into Co-Development Agreement Targeting Oral Disease
Press Release

Flightpath Biosciences and the Forsyth Institute Enter Into Co-Development Agreement Targeting Oral Disease

 Read More